Utility of the neutrophil-to-lymphocyte ratio and the ratio of neutrophil-to-lymphocyte ratio after and before adverse events for differential diagnosis of immune-related adverse events and bacterial infections in cancer patients treated with PD-(L)1 inhibitors
Year: 2025
Type: article
Study design: Observational Study
Source: Journal of Leukocyte Biology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: G2574122095, G7226244953, G8086093334
OpenAlex ID: W4408420950
